In non-small cell lung cancer, Xu et al. found that CSRNP1 is downregulated, and its silencing promotes cancer cell malignant phenotype, possibly through the AKT/MDM2/p53 pathway, indicating a tumor-suppressive role [14]. Here, CSRNP1 is linked to neoplasm.